首页|兰索拉唑联合度洛西汀治疗对胃食管反流病患者症状和生活质量的影响

兰索拉唑联合度洛西汀治疗对胃食管反流病患者症状和生活质量的影响

扫码查看
目的 胃食管反流病(GERD)会对患者身心健康产生不良反应,分析兰索拉唑联合度洛西汀治疗方案的应用效果.方法 50 例GERD患者,以随机数字表法分为对照组与研究组,每组 25 例.对照组采用兰索拉唑治疗,研究组在对照组基础上联合度洛西汀治疗.对比两组不良情绪与症状、食管远端平滑肌运动功能、生活质量.结果 治疗后,两组汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)、胃食管反流病自测量表(GerdQ)评分均低于本组治疗前,且研究组HAMA评分(6.37±1.41)分、HAMD评分(10.28±0.41)分、GerdQ评分(5.37±0.49)分低于对照组的(9.27±2.05)、(13.27±0.62)、(9.25±2.41)分(P<0.05).治疗后,两组食管下括约肌静息压(LESP)、下括约肌松弛率(LESRR)、远端收缩积分(DCI)均高于本组治疗前;且研究组食管LESP、LESRR、DCI分别为(20.26±1.89)mm Hg(1 mm Hg=0.133 kPa)、(99.37±8.14)%、(425.39±95.42)mm Hg·s·cm,高于对照组的(17.13±1.12)mm Hg、(90.27±7.46)%、(299.25±92.34)mm Hg·s·cm(P<0.05).治疗后,两组烧心、吞咽、药物影响、一般健康状态评分均低于本组治疗前;且研究组烧心、吞咽、药物影响、一般健康状态评分分别为(2.19±0.11)、(2.19±0.37)、(2.35±0.15)、(2.38±0.16)分,低于对照组的(5.73±1.42)、(5.93±0.64)、(4.96±1.41)、(4.83±0.43)分(P<0.05).结论 GERD患者不仅有躯体表现症状,且患者的心理状态也受到影响,应用兰索拉唑联合度洛西汀治疗方案有利于促进病情转归,改善患者不良情绪、生活质量,具有较高的临床应用价值,值得推广.
Effect of lansoprazole combined with duloxetine on symptoms and quality of life in patients with gastroesophageal reflux disease
Objective Gastroesophageal reflux disease(GERD)can have adverse effects on the physical and mental health of patients.This paper analyze the therapeutic effect of lansoprazole combined with duloxetine.Methods 50 patients with GERD were divided into a control group and a study group by random number table method,with 25 cases in each group.The control group was treated with lansoprazole,and the study group was treated with duloxetine based on the control group.The negative mood and symptoms,motor function of distal esophageal smooth muscle and quality of life were compared between the two groups.Results After treatment,the scores of Hamilton Anxiety Scale(HAMA),Hamilton Depression Scale(HAMD)and Gastroesophageal Reflux Disease Questionnaire(GerdQ)in both groups were lower than those before treatment;the study group had HAMA score of(6.37±1.41)points,HAMD score of(10.28±0.41)points and GerdQ score of(5.37±0.49)points,which were lower than(9.27±2.05),(13.27±0.62)and(9.25±2.41)points in the control group(P<0.05).After treatment,the lower esophageal sphincter resting pressure(LESP),lower esophageal sphincter relaxation rate(LESRR)and distal contractile integral(DCI)in both groups were higher than those before treatment;LESP,LESRR and DCI of the study group were(20.26±1.89)mm Hg(1 mm Hg=0.133 kPa),(99.37±8.14)%and(425.39±95.42)mm Hg·s·cm,which were higher than(17.13±1.12)mm Hg,(90.27±7.46)%and(299.25±92.34)mm Hg·s·cm in the control group(P<0.05).After treatment,the scores of heartburn,swallowing,drug influence and general health status in both groups were lower than those before treatment;the scores of heartburn,swallowing,drug influence and general health status in the study group were(2.19±0.11),(2.19±0.37),(2.35±0.15)and(2.38±0.16)points,which were lower than(5.73±1.42),(5.93±0.64),(4.96±1.41)and(4.83±0.43)points in the control group(P<0.05).Conclusion GERD patients not only have physical symptoms,and the psychological state of patients is also affected.The application of lansoprazole combined with duloxetine treatment program is conducive to promote the regression of the disease,improve the patient's bad mood,quality of life,which has high clinical application value and is worth promoting.

Gastroesophageal reflux diseaseLansoprazoleDuloxetineSymptomsQuality of life

潘石楠

展开 >

342203 赣州市寻乌县晨光镇中心卫生院

胃食管反流病 兰索拉唑 度洛西汀 症状 生活质量

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(13)